fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

The Case for CBD: Tourette’s

Published

on

Revolutions generally demand a series of steps. Initially, the public zeitgeist is arranged around a number of important assumptions. Those assumptions guide perception, interpretation, and conclusion in many ways.

As new methods and ideas begin to develop, all of those assumptions become obstacles for the process of progress.

Such has been the path along which has run the freight train of research advocating for CBD as a preventative and therapeutic tool in the healthcare industry in recent years. Yet another example of this process is the evidence of efficacy for CBD in the treatment of Tourette’s syndrome.

Tourette’s is a very interesting example of a case study for something tailor-made for an evolution toward greater reliance upon CBD is a powerful tool. Why, because Tourette’s appears, for all intents and purposes, to be a perfect candidate for the application of CBD as a therapeutic instrument.

Wrapping Your Arms around Tourette’s Syndrome

TS is an uncommon disorder of a neuropsychiatric nature that generally manifests during the very early years of life. Essentially, control over the verbal and the motor define this tragic syndrome.

Involuntary gestures, often referred to as “tics”, define this condition in many ways. These are involuntary and often repetitive in generally ostracize those stricken with this sad condition.

As should be clear, the social stigma that arises from the exhibition of these involuntary gestures and expressions dominate the discomfort exhibited by this condition. While patients suffer from a wide range of severity in this aspect, the suffering can rarely be overlooked.

As it turns out, Tourette’s would appear to be generally genetic in derivation. In other words, for those suffering from this tragic condition it was simply in the cards.

How CBD Can Make a Difference

As we begin to consider the role of CBD in cases of Tourette’s, it’s important to understand that research evidence already exists in favor of CBD as an important coping tool for those genetically saddled with this terrible condition.

While this is remarkable in its own right and should be considered another powerful example of the importance of CBD in challenging the assumptions of the medical and scientific establishment as it now stands, it really shouldn’t be a surprise. In fact, CBD seems tailor-made for this exact situation.

However, the fact remains that a great deal of research need yet be done. The full data set has not yet been built out, and yet so many would benefit so greatly if that task has been accomplished.

While the situation isn’t perfect at this point from a research perspective, there are many facts we already have at hand in an applied sense. For example, the end CBI has been cited to powerful effect in support of the role of CBD as an important coping tool in the management of Tourette’s syndrome.

In related documentation, 64 patients were interviewed following the use of CBD as a key tool. 17 of them produced data worth considering. Of those 17, 14 – well over 80% – stipulated that CBD made a powerful impact, including a reduction or complete remission of the important symptoms defining their condition.

There is other evidence as well the bears upon the notion that CBD impacts and undermines the obsessive-compulsive nature so powerfully intertwined with Tourette’s.

At the end of the day, there is cause to consider the need for a great deal of additional research. But results so far are highly encouraging, and we hope that researchers take up the baton of the path that has already been laid down, thus potentially improving the lives of so many suffering from this physically and psychologically painful condition.

CBD CONDITIONS & TREATMENTS

CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million

Published

on

CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading

CBD CONDITIONS & TREATMENTS

Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group

Published

on

Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading

CBD CONDITIONS & TREATMENTS

Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida

Published

on

Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories